Chenyuan Gong

1.1k total citations
36 papers, 893 citations indexed

About

Chenyuan Gong is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Chenyuan Gong has authored 36 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Immunology and 7 papers in Pharmacology. Recurrent topics in Chenyuan Gong's work include Immune Cell Function and Interaction (10 papers), Immune cells in cancer (8 papers) and Retinal Diseases and Treatments (6 papers). Chenyuan Gong is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Immune cells in cancer (8 papers) and Retinal Diseases and Treatments (6 papers). Chenyuan Gong collaborates with scholars based in China, United States and Australia. Chenyuan Gong's co-authors include Lili Ji, Zhengtao Wang, Bin Lü, Xiaowen Zhu, Shiguo Zhu, Chao Yao, Shiguo Zhu, Li Yang, Fang Cheng and Yuchen Sheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Chenyuan Gong

34 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenyuan Gong China 19 466 216 181 146 138 36 893
Eleni Bagli Greece 13 368 0.8× 81 0.4× 70 0.4× 70 0.5× 81 0.6× 27 744
Zengyang Yu China 15 255 0.5× 178 0.8× 73 0.4× 130 0.9× 52 0.4× 25 671
Lingyu Luo China 19 776 1.7× 77 0.4× 176 1.0× 113 0.8× 203 1.5× 37 1.3k
Jinghua Zhang China 18 426 0.9× 120 0.6× 62 0.3× 56 0.4× 136 1.0× 41 765
Marita Hernández Spain 20 684 1.5× 157 0.7× 94 0.5× 80 0.5× 148 1.1× 33 1.1k
Mohd Farhan Macao 11 507 1.1× 64 0.3× 88 0.5× 43 0.3× 192 1.4× 14 801
Sheridan Henness Australia 16 305 0.7× 190 0.9× 184 1.0× 102 0.7× 73 0.5× 20 866
Jingang Cui China 16 511 1.1× 96 0.4× 34 0.2× 51 0.3× 198 1.4× 39 825
Hiroshi Kosano Japan 16 551 1.2× 82 0.4× 105 0.6× 62 0.4× 100 0.7× 46 1.0k

Countries citing papers authored by Chenyuan Gong

Since Specialization
Citations

This map shows the geographic impact of Chenyuan Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyuan Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyuan Gong more than expected).

Fields of papers citing papers by Chenyuan Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenyuan Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyuan Gong. The network helps show where Chenyuan Gong may publish in the future.

Co-authorship network of co-authors of Chenyuan Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Chenyuan Gong. A scholar is included among the top collaborators of Chenyuan Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenyuan Gong. Chenyuan Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Weiming, Dan Hu, Chenyuan Gong, et al.. (2025). Grain-sized moxibustion activates dendritic cells to enhance the antitumor immunity of cancer vaccines. Chinese Medicine. 20(1). 73–73.
2.
Gong, Chenyuan, Rujun Zhang, Dan Hu, et al.. (2024). Euphohelioscopin A enhances NK cell antitumor immunity through GSDME-triggered pyroptosis. Journal of Leukocyte Biology. 116(3). 621–631. 3 indexed citations
3.
Cheng, Fang, et al.. (2024). Traditional Chinese Medicine for Cancer Treatment. The American Journal of Chinese Medicine. 52(3). 583–604. 23 indexed citations
4.
5.
Zhu, Xinyue, Zhongxian Chen, Lixin Wang, et al.. (2024). Rocaglamide regulates iron homeostasis by suppressing hepcidin expression. Free Radical Biology and Medicine. 219. 153–162. 3 indexed citations
6.
Cheng, Fang, Yangli Liu, Yufu Zhou, et al.. (2023). Ailanthone inhibits non-small cell lung cancer growth and metastasis through targeting UPF1/GAS5/ULK1 signaling pathway. Phytomedicine. 128. 155333–155333. 18 indexed citations
7.
Gong, Chenyuan, et al.. (2021). Diterpenoids from Euphorbia helioscopia and their enhancement of NK cell-mediated killing of NSCLC cells. Bioorganic Chemistry. 119. 105534–105534. 13 indexed citations
8.
Xu, Zihang, Jun Shen, Lin Su, et al.. (2021). Pain Relief Dependent on IL-17–CD4+ T Cell–β-Endorphin Axis in Rat Model of Brachial Plexus Root Avulsion After Electroacupuncture Therapy. Frontiers in Neuroscience. 14(4). 55–55. 8 indexed citations
9.
Yan, Xuewei, Chao Yao, Fang Cheng, et al.. (2021). Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. International Journal of Biological Sciences. 18(2). 585–598. 60 indexed citations
10.
Cheng, Fang, et al.. (2020). Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer. Journal of Cellular and Molecular Medicine. 24(6). 3282–3291. 34 indexed citations
11.
Xu, Zihang, Fei Zhang, Fei Liu, et al.. (2019). Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway. Journal of Ethnopharmacology. 234. 180–188. 36 indexed citations
12.
Yao, Chao, Xiaowen Zhu, Chenyuan Gong, et al.. (2017). Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1. British Journal of Cancer. 117(11). 1621–1630. 40 indexed citations
13.
Yu, Zengyang, Bin Lü, & Chenyuan Gong. (2016). Streptozotocin induced diabetic retinopathy in C57 mice and the expression of some pro-angiogenic molecules. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Luo, Yingbin, Jianchun Wu, Xiaowen Zhu, et al.. (2016). NK Cell-Dependent Growth Inhibition of Lewis Lung Cancer by Yu-Ping-Feng, an Ancient Chinese Herbal Formula. Mediators of Inflammation. 2016. 1–7. 23 indexed citations
15.
Gong, Chenyuan. (2016). The Development of Diabetic Retinopathy in Goto-Kakizaki Rat and the Expression of Angiogenesis-Related Signals. The Chinese Journal of Physiology. 預刊文章(預刊文章). 1–9. 23 indexed citations
16.
Gong, Chenyuan, Chao Yao, Xiaowen Zhu, et al.. (2015). A High-Throughput Assay for Screening of Natural Products that Enhanced Tumoricidal Activity of NK Cells. Biological Procedures Online. 17(1). 12–12. 13 indexed citations
17.
Shen, Kaikai, Lili Ji, Bin Lü, et al.. (2014). Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2-MAPKs signaling cascade. Chemico-Biological Interactions. 218. 99–106. 44 indexed citations
18.
Gong, Chenyuan, Zengyang Yu, Bin Lü, et al.. (2014). Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism. Vascular Pharmacology. 62(3). 134–142. 43 indexed citations
19.
Gong, Chenyuan, Bin Lü, Qianwen Hu, & Lili Ji. (2013). Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor.. SHILAP Revista de lepidopterología. 6(5). 573–7. 33 indexed citations
20.
Ji, Lili, Chenyuan Gong, Yibo Ma, et al.. (2012). Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways. Biochemical Pharmacology. 84(6). 784–792. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleni Bagli Breakdown of academic impact, for papers by Zengyang Yu Breakdown of academic impact, for papers by Lingyu Luo Breakdown of academic impact, for papers by Jinghua Zhang Breakdown of academic impact, for papers by Marita Hernández Breakdown of academic impact, for papers by Mohd Farhan Breakdown of academic impact, for papers by Sheridan Henness Breakdown of academic impact, for papers by Jingang Cui Breakdown of academic impact, for papers by Hiroshi Kosano
Rankless by CCL
2026